Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


DuPont to acquire Taxon Biosciences

DuPont has agreed to acquire the US microbial genomics company, Taxon Biosciences (Tiburon, California), for an undisclosed sum. It has a broad intellectual property holding in the field of microbial bioconsortia and microbial genomics products that will contribute to the development of new DuPont crop protection products for seed, foliar and soil application to arable crops, fruit and vegetables, the company points out. "The acquisition of Taxon will complement and enhance our in-house microbial discovery programmes," says Frank DeGennaro, director of DuPont Biologicals. "With this added capability, we expect to accelerate our time from discovery to market and we are field testing biological discovery leads identified by Taxon this year," Mr DeGennaro adds. Crop biologicals include microbes, plant extracts and other natural substances to control pests and improve plant health, quality and yield. As part of an integrated approach to control pests, they can provide more choice and flexibility for growers and complement agrochemical and seed products, DuPont points out.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts